EDIT

Quote

Short

News

Articles

Message Board

Buy Recommendation Issued On EDIT By H.C. Wainwright

August 15, 2025 08:15:10 am

Source: KlickAnalytics

2025-08-15 08:15:10 ET

H.C. Wainwright analyst issues BUY recommendation for EDIT on August 15, 2025 10:14AM ET.

The previous analyst recommendation was Buy.

EDIT was trading at $2.96 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 12 - Buy, 9 - Hold, 2 - Sell recommendations .

Historical Analyst Recommendations

Latest 10 recommendations< ...
Full story available on KlickAnalytics.com

Editas Medicine Inc.

NASDAQ: EDIT

EDIT Trading

2.64% G/L:

$2.675 Last:

880,242 Volume:

$2.61 Open:

mwn-ir Ad 300

EDIT Latest News

March 09, 2026 09:03:20 pm

EDIT Price Target Alert: $6.00. Issued by Robert W. Baird

March 09, 2026 07:00:00 am

Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates

March 04, 2026 06:00:52 am

Expected US Company Earnings on Wednesday, March 4th, 2026

January 28, 2026 08:05:23 am

Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine

EDIT Stock Data

Market Cap $174,737,401

Float 95,568,668

Insiders Ownership 0.4%

Institutions 71

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://www.editasmedicine.com

Country US

City Cambridge

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App